Jpmorgan Chase & CO Gelesis Holdings, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.14 Trillion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 18, 2023
BUY
$0.11 - $0.52 $1,504 - $7,114
13,681 Added 104.36%
26,791 $4,000
Q1 2023

May 11, 2023
SELL
$0.11 - $0.52 $979 - $4,629
-8,903 Reduced 40.44%
13,110 $2,000
Q4 2022

Feb 13, 2023
BUY
$0.22 - $0.51 $2,975 - $6,897
13,524 Added 159.31%
22,013 $7,000
Q3 2022

Nov 14, 2022
BUY
$0.08 - $1.34 $257 - $4,310
3,217 Added 61.02%
8,489 $9,000
Q2 2022

Aug 11, 2022
BUY
N/A
5,272 New
5,272 $8,000

Others Institutions Holding GLS

# of Institutions
1
Shares Held
4.7K
Call Options Held
0
Put Options Held
0
View Full List

About GELESIS HOLDINGS, INC.

GLS Quotes by TradingView
  • Ticker GLS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,946,704
  • Market Cap $1.46M
  • Description
  • Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...
More about GLS
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email